<DOC>
	<DOC>NCT00735020</DOC>
	<brief_summary>This trial is designed to evaluate safety, tolerability and immunogenicity of a bedside mixing formulation of adjuvanted influenza vaccines.</brief_summary>
	<brief_title>Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy 18 to 39 year old males and females who are in good health and have provided informed consent prior to enrollment serious medical conditions allergies to vaccine components, including but not limited to egg/chicken products reduced immune function recent use of immunosuppressive therapy recent use of influenza vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>influenza</keyword>
	<keyword>vaccine</keyword>
	<keyword>adjuvants</keyword>
	<keyword>flu</keyword>
</DOC>